Letter to the Editor : "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy"
J Crit Care
.
2022 Aug:70:154058.
doi: 10.1016/j.jcrc.2022.154058.
Epub 2022 May 11.
Authors
Patrick M Honore
1
,
Sebastien Redant
2
,
Pharan Djimafo
3
,
Thierry Preseau
4
,
Bogdan Vasile Cismas
5
,
Keitiane Kaefer
3
,
Leonel Barreto Gutierrez
6
,
Sami Anane
7
,
Andrea Gallerani
8
,
Rachid Attou
9
Affiliations
1
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Patrick.Honore@CHU-Brugmann.be.
2
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Sebastien.Redant@CHU-Brugmann.be.
3
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
4
ED Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Thierry.Preseau@CHU-Brugmann.be.
5
ED Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Bogdanvasile.CISMAS@chu-brugmann.be.
6
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Leonel.BarretoGutierrez@chu-brugmann.be.
7
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Sami.Anane@CHU-Brugmann.be.
8
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Andrea.Gallerani@CHU-Brugmann.be.
9
ICU Dept, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. Electronic address: Rachid.Attou@CHU-Brugmann.be.
PMID:
35561558
DOI:
10.1016/j.jcrc.2022.154058
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Cefepime
Ceftazidime*
Continuous Renal Replacement Therapy*
Critical Illness / therapy
Humans
Renal Replacement Therapy
Substances
Anti-Bacterial Agents
Cefepime
Ceftazidime